Open Science Research Excellence

ICAMAES 2020 : 22nd International Conference on Antidepressant Medications, Adverse Effects and Suicide

November 2 - 3, 2020
San Francisco, USA
For direction to the venue you can use google maps.
Discipline Pharmacological and Pharmaceutical Sciences
Subdiscipline Antidepressant Medications, Adverse Effects and Suicide
Event Type Conference
Delegate Fee 250euro-500euro

Conference Aims and Objectives

The ICAMAES 2020: 22nd International Conference on Antidepressant Medications, Adverse Effects and Suicide aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Antidepressant Medications, Adverse Effects and Suicide. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Antidepressant Medications, Adverse Effects and Suicide.

Call for Contributions

All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Antidepressant Medications, Adverse Effects and Suicide are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.